Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Common Equity (2020 - 2025)

Historic Common Equity for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $44.3 million.

  • Rapid Micro Biosystems' Common Equity fell 4745.71% to $44.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.3 million, marking a year-over-year decrease of 4745.71%. This contributed to the annual value of $75.4 million for FY2024, which is 3613.64% down from last year.
  • As of Q3 2025, Rapid Micro Biosystems' Common Equity stood at $44.3 million, which was down 4745.71% from $54.5 million recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' Common Equity ranged from a high of $234.7 million in Q3 2021 and a low of -$164.5 million during Q2 2021
  • Over the past 5 years, Rapid Micro Biosystems' median Common Equity value was $122.9 million (recorded in 2023), while the average stood at $116.6 million.
  • Per our database at Business Quant, Rapid Micro Biosystems' Common Equity soared by 27399.18% in 2021 and then plummeted by 4745.71% in 2025.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' Common Equity stood at $221.0 million in 2021, then dropped by 25.71% to $164.2 million in 2022, then decreased by 28.13% to $118.0 million in 2023, then plummeted by 36.14% to $75.4 million in 2024, then tumbled by 41.17% to $44.3 million in 2025.
  • Its Common Equity was $44.3 million in Q3 2025, compared to $54.5 million in Q2 2025 and $65.5 million in Q1 2025.